冠状动脉疾病

首页 » 常识 » 问答 » 1029国际期刊速递丨今日热点心脏
TUhjnbcbe - 2020/12/12 11:28:00
北京中科高效抗白个性施术 http://www.hhlsq.com/
TODAY今日发布JAMAEarlyRecent,Oct28,今日发布02篇JAMACardiologyEarlyRecent,Oct28,今日发布11篇NEJMOct29,:(18)今日发布24篇CATHETERCARDIOINTEEarlyRecent,Oct28,今日发布01篇ClinicalCardiologyEarlyRecent,Oct28,今日发布01篇JournalofCardiacSurgeryEarlyRecent,Oct28,今日发布01篇JournalofClinicalUltrasoundNov01,:48(9),i,-今日发布15篇RECOMMEND推荐阅读01冠状动脉钙扫描与阿司匹林净效益在动脉粥样硬化性心血管疾病一级预防中的价值JAMACardiologyEzimamakaAjufo,ColbyR.Ayers,etc.昨天23:06ImportanceHighercoronaryarterycalcium(CAC)identifiesindividualsatincreasedatheroscleroticcardiovasculardisease(ASCVD)risk.Whetheritcanalsoidentifyindividualslikelytoderivenetbenefitfromaspirintherapyisunclear.冠状动脉高钙(CAC)可识别动脉粥样硬化性心血管疾病(ASCVD)风险增加的个体。目前还不清楚它是否也能确定哪些人可能从阿司匹林疗法中获得净收益。ObjectiveToexaminetheassociationbetweenCAC,bleeding,andASCVDandexplorethenetestimatedeffectofaspirinatdifferentCACthresholds.研究CAC、出血和ASCVD之间的关系,探讨不同CAC阈值下阿司匹林的净估计效应。Design,Setting,andParticipantsProspectivepopulation-basedcohortstudyofDallasHeartStudyparticipants,freefromASCVDandnottakingaspirinatbaseline.DatawereanalyzedbetweenFebruary1,,andJuly15,.达拉斯心脏病研究参与者的前瞻性人群队列研究,无ASCVD,基线不服用阿司匹林。数据分析时间为年2月1日至年7月15日。ExposuresCoronaryarterycalciumscoreinthefollowingcategories:0,1-99,andorhigher.冠状动脉钙分为以下几类:0、1-99和或更高。MainOut
1
查看完整版本: 1029国际期刊速递丨今日热点心脏